FNBT
NVO

FineMark National Bank & Trust’s Novo Nordisk NVO Stock Holding History

FineMark National Bank & Trust’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,339
Closed -$241K – 464
2025
Q3 		$241K Buy
4,339
+370
+9% +$21.7K 0.01% 403
2025
Q2 		$274K Buy
3,969
+474
+14% +$32.2K 0.01% 390
2025
Q1 		$243K Buy
3,495
+892
+34% +$73.7K 0.01% 383
2024
Q4 		$224K Sell
2,603
-2,463
-49% -$266K 0.01% 391
2024
Q3 		$603K Sell
5,066
-417
-8% -$55.6K 0.02% 261
2024
Q2 		$783K Sell
5,483
-3,373
-38% -$447K 0.03% 222
2024
Q1 		$1.14M Buy
8,856
+2,089
+31% +$249K 0.04% 197
2023
Q4 		$700K Buy
6,767
+303
+5% +$30K 0.03% 237
2023
Q3 		$588K Buy
6,464
+340
+6% +$30K 0.03% 247
2023
Q2 		$496K Buy
6,124
+126
+2% +$10.3K 0.02% 281
2023
Q1 		$477K Sell
5,998
-214
-3% -$15.2K 0.02% 278
2022
Q4 		$420K Sell
6,212
-276
-4% -$16.2K 0.02% 278
2022
Q3 		$323K Buy
6,488
+1,388
+27% +$74.4K 0.02% 303
2022
Q2 		$284K Sell
5,100
-828
-14% -$45.9K 0.01% 348
2022
Q1 		$329K Buy
5,928
+214
+4% +$11K 0.01% 348
2021
Q4 		$320K Sell
5,714
-9,018
-61% -$489K 0.01% 372
2021
Q3 		$707K Sell
14,732
-752
-5% -$36.4K 0.03% 243
2021
Q2 		$649K Buy
15,484
+540
+4% +$20.9K 0.03% 265
2021
Q1 		$504K Buy
14,944
+9,084
+155% +$324K 0.02% 286
2020
Q4 		$205K Sell
5,860
-7,308
-55% -$253K 0.01% 397
2020
Q3 		$457K Sell
13,168
-892
-6% -$29.7K 0.02% 248
2020
Q2 		$460K Sell
14,060
-220
-2% -$7.02K 0.03% 244
2020
Q1 		$430K Buy
+14,280
New +$425K 0.03% 234
2019
Q4 		– Sell
-9,636
Closed -$249K – 389
2019
Q3 		$249K Sell
9,636
-486
-5% -$12.3K 0.01% 316
2019
Q2 		$258K Buy
10,122
+810
+9% +$20K 0.01% 310
2019
Q1 		$244K Sell
9,312
-7,686
-45% -$189K 0.01% 301
2018
Q4 		$392K Buy
16,998
+7,998
+89% +$178K 0.03% 258
2018
Q3 		$212K Buy
+9,000
New +$220K 0.01% 306
2015
Q4 		– Sell
-4,298
Closed -$117K – 1439
2015
Q3 		$117K Sell
4,298
-360
-8% -$10.2K 0.02% 420
2015
Q2 		$128K Buy
4,658
+224
+5% +$6.3K 0.02% 420
2015
Q1 		$118K Buy
4,434
+528
+14% +$12.2K 0.02% 448
2014
Q4 		$82K Sell
3,906
-98
-2% -$2.19K 0.01% 538
2014
Q3 		$95K Buy
4,004
+572
+17% +$13.2K 0.02% 487
2014
Q2 		$79K Buy
3,432
+110
+3% +$2.43K 0.01% 520
2014
Q1 		$76K Buy
3,322
+2,952
+798% +$62.9K 0.01% 511
2013
Q4 		$7K Sell
370
-80
-18% -$1.39K ﹤0.01% 1093
2013
Q3 		$8K Sell
450
-6,890
-94% -$116K ﹤0.01% 1024
2013
Q2 		$114K Buy
+7,340
New +$122K 0.03% 380

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FineMark National Bank & Trust's NVO Position: Q4 2025 in Review

FineMark National Bank & Trust sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 4,339 shares — an estimated $241K sold.

FineMark National Bank & Trust first reported a position in NVO in Q2 2013 and held it in 38 quarters. The position peaked at $1.14M in Q1 2024. 1,414 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • FineMark National Bank & Trust reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
  • FineMark National Bank & Trust sold 4,339 Novo Nordisk shares in Q4 2025, an estimated $241K.
  • FineMark National Bank & Trust first reported a position in Novo Nordisk in Q2 2013 and held it in 38 quarters.
  • FineMark National Bank & Trust's Novo Nordisk position peaked at $1.14M in Q1 2024.
  • 1,414 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on FineMark National Bank & Trust's 13F filing for Q4 2025, filed 12 Feb 2026.